ES2132162T3 - Composiciones farmaceuticas que incluyen un farmaco, una sustancia polimerica reticulada, un aceite y un agente tensioactivo. - Google Patents

Composiciones farmaceuticas que incluyen un farmaco, una sustancia polimerica reticulada, un aceite y un agente tensioactivo.

Info

Publication number
ES2132162T3
ES2132162T3 ES93118278T ES93118278T ES2132162T3 ES 2132162 T3 ES2132162 T3 ES 2132162T3 ES 93118278 T ES93118278 T ES 93118278T ES 93118278 T ES93118278 T ES 93118278T ES 2132162 T3 ES2132162 T3 ES 2132162T3
Authority
ES
Spain
Prior art keywords
pharmaceutical
oil
compositions including
surgeon
pharmaceutical compositions
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93118278T
Other languages
English (en)
Inventor
Fabio Carli
Daniela Lombardi
Pierandrea Esposito
Luca Dobetti
Luigi Boltri
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Vectorpharma SpA
Original Assignee
Vectorpharma SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Vectorpharma SpA filed Critical Vectorpharma SpA
Application granted granted Critical
Publication of ES2132162T3 publication Critical patent/ES2132162T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Compositions Of Macromolecular Compounds (AREA)

Abstract

LAS COMPOSICIONES FARMACEUTICAS QUE INCLUYEN UNA MEDICINA LIGERAMENTE SOLUBLE INCORPORADA, QUE SE HINCHA EN EL AGUA, PERO POLIMERO DEGRADADO INSOLUBLE EN AGUA, UN AGENTE SURFACTANTE, Y UN ACEITE, MUESTRAN UNA DISOLUCION MAYOR Y, CONSECUENTEMENTE, BIODISPONIBILIDAD CON RESPECTO A LA MEDICINA TAL COMO ES, O USADA CON UN PORTADOR POLIMERICO DEL TIPO CITADO.
ES93118278T 1992-11-13 1993-11-11 Composiciones farmaceuticas que incluyen un farmaco, una sustancia polimerica reticulada, un aceite y un agente tensioactivo. Expired - Lifetime ES2132162T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITMI922603A IT1256386B (it) 1992-11-13 1992-11-13 Composizioni farmaceutiche comprendenti un farmaco,una sostanza polimerica reticolata,un olio ed un agente tensioattivo

Publications (1)

Publication Number Publication Date
ES2132162T3 true ES2132162T3 (es) 1999-08-16

Family

ID=11364286

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93118278T Expired - Lifetime ES2132162T3 (es) 1992-11-13 1993-11-11 Composiciones farmaceuticas que incluyen un farmaco, una sustancia polimerica reticulada, un aceite y un agente tensioactivo.

Country Status (7)

Country Link
US (1) US6107276A (es)
EP (1) EP0598337B1 (es)
AT (1) ATE178787T1 (es)
DE (1) DE69324442T2 (es)
ES (1) ES2132162T3 (es)
GR (1) GR3030732T3 (es)
IT (1) IT1256386B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2159419C (en) * 1994-10-17 2006-07-04 Pieter De Haan Solid pharmaceutical composition comprising an excipient capable of binding water
NL1003503C2 (nl) * 1996-07-04 1998-01-07 Negma Steba International Dev Farmaceutische samenstelling voor orale toediening.
HUP9603364A2 (hu) * 1996-12-06 1998-12-28 Chinoin Gyógyszer és Vegyészeti Termékek Gyára Rt. Ipriflavont tartalmazó csonthiány pótlására szolgáló gyógyászati készítmény és eljárás előállítására
NZ314702A (en) * 1997-04-29 1998-07-28 Bernard Charles Sherman Pharmaceutical composition comprising a cyclosporin in a solvent system of acetylated monoglycerides and a surfactant and optionally a hydrophilic solvent
AR012627A1 (es) 1997-04-29 2000-11-08 Sherman Bernard Charles Pre-concentrado de emulsion que comprende una ciclosporina y monoglicerido acetilado
IT1293835B1 (it) * 1997-08-08 1999-03-10 Foscama Biomed Chim Farma Composizioni farmaceutiche orali in forma solida a cessione modulata contenenti nicorandil e procedimento per la loro preparazione
US6063762A (en) * 1997-12-05 2000-05-16 Chong Kun Dang Corp. Cyclosporin-containing microemulsion preconcentrate composition
ATE404172T1 (de) 1998-12-30 2008-08-15 Dexcel Ltd Dispergierbares konzentrat zur verabreichung von cyclosporin
ES2251985T3 (es) * 1999-03-24 2006-05-16 R.P. Scherer Technologies, Inc. Particula granulada para mejorar la solubilidad acuosa de farmacos, y su procedimiento de preparacion.
CA2372994C (en) * 1999-06-04 2010-03-23 Alza Corporation Implantable gel compositions and method of manufacture
US7732404B2 (en) 1999-12-30 2010-06-08 Dexcel Ltd Pro-nanodispersion for the delivery of cyclosporin
DE10046541A1 (de) * 2000-09-19 2002-03-28 Knoll Ag Mechanisch stabile darreichungsformen, enthaltend Ubichinone
US6300377B1 (en) * 2001-02-22 2001-10-09 Raj K. Chopra Coenzyme Q products exhibiting high dissolution qualities
WO2003007928A1 (fr) * 2001-07-17 2003-01-30 Idemitsu Kosan Co., Ltd. Medicaments prophylactiques contre l'ascite pour la volaille
FR2832065B1 (fr) * 2001-11-13 2004-11-05 Besins Int Belgique Composition pharmaceutique a base de progesterone micronisee son procede de preparation et ses utilisations
CN100563658C (zh) * 2003-11-14 2009-12-02 味之素株式会社 苯丙氨酸衍生物的固体分散体或固体分散体医药制剂
WO2005079752A2 (en) * 2004-02-11 2005-09-01 Rubicon Research Private Limited Controlled release pharmaceutical compositions with improved bioavailability
CN101410123A (zh) 2006-03-28 2009-04-15 杰佛林制药公司 低剂量的双氯芬酸和β－环糊精的制剂
US8999381B2 (en) 2007-09-27 2015-04-07 Wockhardt Ltd. Self-emulsifying pharmaceutical compositions of rhein or diacerein
SG10202010355PA (en) * 2010-03-12 2020-11-27 Berg Llc Intravenous formulations of coenzyme q10 (coq10) and methods of use thereof
IE20100799A1 (en) * 2010-12-22 2012-08-01 Eurand Pharmaceuticals Ltd Pharmaceutical composites of poorly water soluble drugs and polymers
EP2720680B1 (en) 2011-06-17 2020-02-12 Berg LLC Inhalable pharmaceutical compositions
US10328087B2 (en) 2015-07-23 2019-06-25 Therapeuticsmd, Inc. Formulations for solubilizing hormones
US9687475B1 (en) 2016-03-24 2017-06-27 Ezra Pharma Llc Extended release pharmaceutical formulations with controlled impurity levels
US9675585B1 (en) 2016-03-24 2017-06-13 Ezra Pharma Extended release pharmaceutical formulations
WO2017173044A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd Inc. Steroid hormone compositions in medium chain oils
WO2017173071A1 (en) 2016-04-01 2017-10-05 Therapeuticsmd, Inc. Steroid hormone pharmaceutical composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3224619A1 (de) * 1981-07-14 1983-05-19 Freund Industrial Co., Ltd., Tokyo Orale pharmazeutische zusammensetzung
EP0078430B2 (de) * 1981-10-29 1993-02-10 Bayer Ag Verfahren zur Herstellung von festen, schnellfreisetzenden Arzneizubereitungen mit Dihydropyridinen
GB8403359D0 (en) * 1984-02-08 1984-03-14 Erba Farmitalia Pharmaceutical compositions
DE3524572A1 (de) * 1985-07-10 1987-01-15 Thomae Gmbh Dr K Feste arzneimittelformen zur peroralen anwendung enthaltend 9-deoxo-11-deoxy-9,11-(imino(2-(2-methoxyethoxy)ethyliden)-oxy)-(9s)-erythromycin und verfahren zu ihrer herstellung
ES2119748T3 (es) * 1990-03-23 1998-10-16 Yoshitomi Pharmaceutical Composicion farmaceutica que contiene un farmaco ligeramente soluble en agua.

Also Published As

Publication number Publication date
EP0598337A3 (en) 1995-06-14
DE69324442T2 (de) 1999-08-05
GR3030732T3 (en) 1999-11-30
ATE178787T1 (de) 1999-04-15
ITMI922603A1 (it) 1994-05-13
IT1256386B (it) 1995-12-04
DE69324442D1 (de) 1999-05-20
US6107276A (en) 2000-08-22
ITMI922603A0 (it) 1992-11-13
EP0598337B1 (en) 1999-04-14
EP0598337A2 (en) 1994-05-25

Similar Documents

Publication Publication Date Title
ES2132162T3 (es) Composiciones farmaceuticas que incluyen un farmaco, una sustancia polimerica reticulada, un aceite y un agente tensioactivo.
ES2058503T3 (es) Formulaciones farmaceuticas para uso parenteral.
ES2097787T5 (es) Composicion farmaceutica para la administracion rectal de principios activos que presenta una accion de medicacion prevalentemente topica a nivel del colon.
ES2173943T3 (es) Sulfonas activas de polietilenglicol solubles en agua.
ATE238813T1 (de) Wirkstoffformulierungen mit verzögerter freisetzung
ES2098323T3 (es) Sistema doble redox para la desinfeccion de lentes de contacto.
DK0959873T3 (da) Gelsammensætning og fremgangsmåder
AR027091A1 (es) Forma de dosificacion de farmacos accionada por un hidrogel
AR003908A1 (es) Tableta de liberacion controlada
ES2046214T3 (es) Medicamento con liberacion retardada de la sustancia activa.
ES2139877T3 (es) Agente anti-incrustacion.
ES2052016T3 (es) Composicion emulsionada.
ES2163008T3 (es) Procedimiento para la obtencion de preparados de principios activos en forma de una disolucion solida de principio activo en una matriz polimera, asi como preparados de principios activos obtenidos con este procedimiento.
MX9203477A (es) Composicion bioactiva.
ES2124739T3 (es) Matrices de liberacion sostenida de uso dental.
EP0580861A4 (en) CAPSULE.
AR015360A1 (es) Proceso para la manufactura de una composicion farmaceutica para reducir o prevenir los efectos de la inflamacion; dicha composicion farmaceutica y unelemento para aplicar la composicion farmaceutica en dicho proceso
ES2096103T3 (es) Preparacion de comprimidos de resistencia incrementada.
ES2163629T3 (es) Dispositivo de osteosintesis implantable.
ES2116376T3 (es) Conjugados peg-interferon.
ES2149264T3 (es) Agente terapeutico para el tratamiento de melanomas.
ES2145557T3 (es) Composiciones de ablandamiento del agua y composiciones detergentes.
ES2091001T3 (es) Capsula que contiene un componente susceptible de degradacion y un polimero compuesto.
ES2177677T3 (es) Soluciones estables de 2-cloro-2`desoxiadenosina.
ES2090655T3 (es) Agentes y composiciones para el modelado del cabello que contienen polimeros hidrofobos para el modelado del cabello.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 598337

Country of ref document: ES